HIV 1 News and Research

RSS

Blocking protein that initiates immune response against viral infections may help combat HIV

In findings they call counterintuitive, a team of UCLA-led researchers suggests that blocking a protein, which is crucial to initiating the immune response against viral infections, may actually help combat HIV.

23 Dec 2016

Heart attack risk for people with HIV nearly 50% higher than predicted

Current methods to predict the risk of heart attack and stroke vastly underestimate the risk in individuals with HIV, which is nearly double that of the general population, reports a new Northwestern Medicine study.

21 Dec 2016

Fly study shows RNA pathway plays major role in normal health and longevity

Humans and other animals carry rogue sequences of DNA in their genomes called transposable elements. To prevent passing TEs to their offspring, they employ the piRNA pathway in their reproductive organs to block the elements from being active in their sperm and eggs.

21 Dec 2016

First large-scale clinical study of long-acting injectable HIV drug begins

The first large-scale clinical trial of a long-acting injectable drug for HIV prevention began today.

21 Dec 2016

How can we tackle antimicrobial resistance?

Antimicrobial resistance happens when bugs, like bacteria, fungi or viruses, change, or evolve, when they’re exposed to drugs, like antibiotics, antifungals, or antivirals. Bugs that develop antimicrobial resistance are sometimes referred to as ‘superbugs’.

20 Dec 2016

Researchers use CRISPR-based genetic screening to identify three promising HIV treatment targets

Investigators from Whitehead Institute, the Ragon Institute of MGH, MIT and Harvard and the Broad Institute of MIT and Harvard have used CRISPR-Cas9 gene-editing technology to identify three promising new targets for treatment of HIV infection.

20 Dec 2016

Penn researchers pinpoint some effective HIV drugs in causing neuronal damage

Antiretroviral drugs have been life-changing therapies for HIV patients, but they can have significant side effects.

16 Dec 2016

Retinoblastoma protein plays larger role in tumor suppression, study finds

The Retinoblastoma protein (pRB) has long been studied for its role in cell growth and the prevention of cancer.

16 Dec 2016

Psychology researcher explores barriers deterring MSM from seeking information on STIs

A researcher at Birmingham City University is undertaking research into the social and cognitive barriers hindering men who have sex with other men (MSM) from finding out more information about sexually transmitted infections (STIs).

15 Dec 2016

O'Neill Institute, NMAC release first of two reports to help prevent HIV in communities of color

Two HIV policy experts from the O'Neill Institute for National and Global Health Law at Georgetown Law working in partnership with NMAC have released the first of two reports to help prevent HIV in communities of color.

15 Dec 2016

New technology that increases Natural Killer cells to stop cancers gets licensed

Our bodies contain Natural Killer (NK) cells - an army that stops cancers and viruses before they can make us sick.

15 Dec 2016

New review shows how automated telephone systems could play vital role in delivery of health care

A new Cochrane Review, summarizing data from 132 trials of automated telephone systems in preventing and managing long-term health conditions, concludes that they probably have the potential to play an important role in the delivery of health care.

15 Dec 2016

Families are probably not financially burdened by their childrens' Down Syndrome medical care

The first study to analyze the out-of-pocket costs to families for the medical care of children and adolescents with Down syndrome finds that monthly costs - averaged over the first 18 years of life - are less than $100 a month more than the costs for care of a typically developing child. The report published in American Journal of Medical Genetics, Part A also finds that the additional costs are lower when the child is older.

14 Dec 2016

NIH scientists create Salmonella-infected mouse model to study life-threatening meningitis

National Institutes of Healthscientists have established in mice a way to study potentially life-threatening meningitis caused by Salmonella.

9 Dec 2016

ABIVAX reports preclinical data on first-in-class drug candidate for functional cure of HIV/AIDS patients

ABIVAX an innovative biotechnology company targeting the immune system to eliminate viral disease, announced today that the Company presented new preclinical data on ABX464, ABIVAX's first-in-class drug candidate for a functional cure of patients with HIV/AIDS, during this week's HIV DART scientific conference in Los Cabos, Mexico.

9 Dec 2016

HIV 1 News and Research

Blocking protein that initiates immune response against viral infections may help combat HIV

Heart attack risk for people with HIV nearly 50% higher than predicted

Fly study shows RNA pathway plays major role in normal health and longevity

First large-scale clinical study of long-acting injectable HIV drug begins

How can we tackle antimicrobial resistance?

Researchers use CRISPR-based genetic screening to identify three promising HIV treatment targets

Penn researchers pinpoint some effective HIV drugs in causing neuronal damage

Retinoblastoma protein plays larger role in tumor suppression, study finds

Psychology researcher explores barriers deterring MSM from seeking information on STIs

O'Neill Institute, NMAC release first of two reports to help prevent HIV in communities of color

New technology that increases Natural Killer cells to stop cancers gets licensed

New review shows how automated telephone systems could play vital role in delivery of health care

Families are probably not financially burdened by their childrens' Down Syndrome medical care

NIH scientists create Salmonella-infected mouse model to study life-threatening meningitis

ABIVAX reports preclinical data on first-in-class drug candidate for functional cure of HIV/AIDS patients

Research findings could pave way for synthesis of biologically active oligopeptides

Study explores men's perceptions of new HIV prevention treatment

Vaxine’s unique adjuvants boost effectiveness of vaccines for battling against infectious diseases

Study finds high rates of marijuana use among Baby Boomers

Project to help those living with HIV launched by Beckman Coulter

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News